{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:52:05Z","timestamp":1788191525098,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Zhejiang Provincial Natural Science Foundation of China","award":["LY18H160020"],"award-info":[{"award-number":["LY18H160020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02808-9","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:05:53Z","timestamp":1751429153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pleiotrophin promote glioma proliferation and invasion by enhancing NF-\u03baB\/SLUG mediated epithelial\u2013mesenchymal transition"],"prefix":"10.1186","volume":"30","author":[{"given":"Hong-Xing","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Ya","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Jue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"9","key":"2808_CR1","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1158\/0008-5472.CAN-19-0749","volume":"79","author":"Z Amoozgar","year":"2019","unstructured":"Amoozgar Z, Jain RK, Duda DG. Role of apelin in glioblastoma vascularization and invasion after anti-VEGF therapy: what is the impact on the immune system? Can Res. 2019;79(9):2104\u20136.","journal-title":"Can Res"},{"issue":"1","key":"2808_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-022-01513-z","volume":"21","author":"K Yang","year":"2022","unstructured":"Yang K, Wu Z, Zhang H, Zhang N, Wu W, Wang Z, et al. Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer. 2022;21(1):1\u201332.","journal-title":"Mol Cancer"},{"key":"2808_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, et al. Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharmacol Res. 2021;171: 105780.","journal-title":"Pharmacol Res"},{"issue":"4","key":"2808_CR4","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00701-023-05544-3","volume":"165","author":"G Chehade","year":"2023","unstructured":"Chehade G, Lawson TM, Lelotte J, Daoud L, Di Perri D, Whenham N, et al. Long-term survival in patients with IDH-wildtype glioblastoma: clinical and molecular characteristics. Acta Neurochir (Wien). 2023;165(4):1075\u201385.","journal-title":"Acta Neurochir (Wien)"},{"key":"2808_CR5","doi-asserted-by":"crossref","unstructured":"Pantalone MR, Rahbar A, Soderberg-Naucler C, Stragliotto G. Valganciclovir as add-on to second-line therapy in patients with recurrent glioblastoma. Cancers. 2022: 14(8)","DOI":"10.3390\/cancers14081958"},{"key":"2808_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jphotobiol.2017.10.035","volume":"178","author":"SA Abdel Gaber","year":"2018","unstructured":"Abdel Gaber SA, M\u00fcller P, Zimmermann W, H\u00fcttenberger D, Wittig R, Abdel Kader MH, et al. ABCG2-mediated suppression of chlorin e6 accumulation and photodynamic therapy efficiency in glioblastoma cell lines can be reversed by KO143. J Photochem Photobiol, B. 2018;178:182\u201391.","journal-title":"J Photochem Photobiol, B"},{"issue":"10","key":"2808_CR7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neo.2018.08.011","volume":"20","author":"K Angara","year":"2018","unstructured":"Angara K, Borin TF, Rashid MH, Lebedyeva I, Ara R, Lin P-C, et al. CXCR2-expressing tumor cells drive vascular mimicry in antiangiogenic therapy\u2013resistant glioblastoma. Neoplasia. 2018;20(10):1070\u201382.","journal-title":"Neoplasia"},{"issue":"6","key":"2808_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/neuonc\/nox206","volume":"20","author":"YK Banasavadi-Siddegowda","year":"2018","unstructured":"Banasavadi-Siddegowda YK, Welker AM, An M, Yang X, Zhou W, Shi G, et al. PRMT5 as a druggable target for glioblastoma therapy. Neuro Oncol. 2018;20(6):753\u201363.","journal-title":"Neuro Oncol"},{"key":"2808_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00384-011-1344-z","volume":"27","author":"Y Kong","year":"2012","unstructured":"Kong Y, Bai P-S, Nan K-J, Sun H, Chen N-Z, Qi X-G. Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer. Int J Colorectal Dis. 2012;27:287\u201398.","journal-title":"Int J Colorectal Dis"},{"key":"2808_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cca.2016.12.030","volume":"466","author":"J Ma","year":"2017","unstructured":"Ma J, Kong Y, Nan H, Qu S, Fu X, Jiang L, et al. Pleiotrophin as a potential biomarker in breast cancer patients. Clin Chim Acta. 2017;466:6\u201312.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"2808_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.jocn.2014.02.020","volume":"21","author":"J Ma","year":"2014","unstructured":"Ma J, Lang B, Wang X, Wang L, Dong Y, Hu H. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma. J Clin Neurosci. 2014;21(11):1885\u201390.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"2808_CR12","first-page":"175","volume":"29","author":"H Wang","year":"2015","unstructured":"Wang H, Wang J. Expression of pleiotrophin in small cell lung cancer. J Biol Regul Homeost Agents. 2015;29(1):175\u20139.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"406","key":"2808_CR13","doi-asserted-by":"publisher","first-page":"ra125","DOI":"10.1126\/scisignal.aaa1690","volume":"8","author":"L Zhang","year":"2015","unstructured":"Zhang L, Kundu S, Feenstra T, Li X, Jin C, Laaniste L, et al. Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas. Sci Signal. 2015;8(406):ra125.","journal-title":"Sci Signal."},{"issue":"1","key":"2808_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/biomedicines11010163","volume":"11","author":"H Ling","year":"2023","unstructured":"Ling H, Xiao H, Luo T, Lin H, Deng J. Role of ferroptosis in regulating the epithelial\u2013mesenchymal transition in pulmonary fibrosis. Biomedicines. 2023;11(1):163.","journal-title":"Biomedicines"},{"issue":"1","key":"2808_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, Wei Y, Wei X. Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Mol Cancer. 2022;21(1):104.","journal-title":"Mol Cancer"},{"issue":"11","key":"2808_CR16","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1111\/jcmm.13213","volume":"21","author":"PS Bai","year":"2017","unstructured":"Bai PS, Xia N, Sun H, Kong Y. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma. J Cell Mol Med. 2017;21(11):3023\u201343.","journal-title":"J Cell Mol Med"},{"key":"2808_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10620-008-0433-5","volume":"54","author":"J Yao","year":"2009","unstructured":"Yao J, Ma Q, Wang L, Zhang M. Pleiotrophin expression in human pancreatic cancer and its correlation with clinicopathological features, perineural invasion, and prognosis. Dig Dis Sci. 2009;54:895\u2013901.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"2808_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"11","key":"2808_CR19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrneph.2013.190","volume":"9","author":"D Holmes","year":"2013","unstructured":"Holmes D. MN linked to improved prognosis in anti-GBM disease. Nat Rev Nephrol. 2013;9(11):626.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2808_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12964-021-00713-2","volume":"19","author":"SE Leggett","year":"2021","unstructured":"Leggett SE, Hruska AM, Guo M, Wong IY. The epithelial\u2013mesenchymal transition and the cytoskeleton in bioengineered systems. Cell Commun Signal. 2021;19(1):32.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"2808_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177964","volume":"12","author":"L Zha","year":"2017","unstructured":"Zha L, He L, Xie W, Cheng J, Li T, Mohsen MO, et al. Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis. PLoS ONE. 2017;12(5): e0177964.","journal-title":"PLoS ONE"},{"issue":"7","key":"2808_CR22","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/neuonc\/noab302","volume":"24","author":"AM Knudsen","year":"2022","unstructured":"Knudsen AM, Halle B, Cedile O, Burton M, Baun C, Thisgaard H, et al. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors. Neuro Oncol. 2022;24(7):1074\u201387.","journal-title":"Neuro Oncol"},{"issue":"1","key":"2808_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY-J, Jackson RA, Thiery JP. EMT. Cell. 2016;166(1):21\u201345.","journal-title":"Cell"},{"key":"2808_CR24","doi-asserted-by":"crossref","unstructured":"Ganguly D, Schmidt MO, Coleman M, Ngo TC, Sorrelle N, Dominguez ATA, et al. Pleiotrophin drives a prometastatic immune niche in breast cancer. J Exp Med. 2023: 220(5)","DOI":"10.1084\/jem.20220610"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02808-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02808-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02808-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:05:56Z","timestamp":1751429156000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02808-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2808"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02808-9","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"545"}}